Johnson & Johnson has a chance to show it’s more than just a rotation winner
Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…
Kennedy presses ahead with plans to reduce antidepressant use
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
How one father built a biotech, Grace Science, to save his daughter
Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed…
FDA approves Vera Therapeutics kidney disease treatment
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Anthropic, AI powerhouse, announces it will begin developing drugs of its own
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Summit Therapeutics (NASDAQ:SMMT) requires weighing the broad potential of artificial intelligence against…
Anthropic launches AI drug discovery program, Claude Science
CEO of Anthropic Dario Amodei attends a working lunch with G7 leaders, G7 outreach partners and global tech…
Anthropic releases Claude Science, sees Claude Code level impact
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Abivax stock soars after new data on bowel disease medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for…